‘Landmark’ Study Revises Molecular Classification of DLBCL

Researchers uncover four genetic subtypes of diffuse large B-cell lymphoma with striking differences in 5-year overall survival, providing a potential path toward precision medicine treatment strategies.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply